ABSTRACT
In this article we will present some aspects of the therapeutic approach to gingival inflammation and lesions of oral mucosa during the 2 months of lockdown, considering the protocols on the spread of SARS-coV-19 virus. We used local therapeutic medication for oral pathology in patients with fixed orthodontic, avoiding as much as possible of therapeutic methods which were at risk of spreading COVID-19 infection. To prevent and limit SARS-CoV-2 Coronavirus contamination before and at the end of orthodontic treatment, the patient rinses the mouth for at least 30 seconds with 1% -1.5% hydrogen peroxide or iodine antiseptic solutions. povidone 0.2% -1% (7,8).
ABSTRACT
The high infection risk in dental offices during COVID-19 pandemic relies on the crucial role of saliva in supporting viral transmission either by airborne droplets and aerosols or by direct-contact. To avoiding cross-infection in dental setting the specific procedures needs fast salivary detecting tests for early diagnosis of both symptomatic and asymptomatic carrier patients. The use of virucidal oral mouthwashes reduces the viral transmission risk mediated through aerosols and salivary droplets. Prior to oral procedures are recommended 30 seconds oral cavity rinses and 30 seconds gargle in the throat with 9 ml 0.2-0.5 % providone-iodine, 15 ml 1-3% hydrogen peroxide, 15 ml 0.05-0.07% cetylpiridinium chloride or 15 ml 0.12% chlorhexidine.